Beta-Blocker Discontinuation in Acute Heart Failure
Nima Alaeiilkhchi, Wade Thompson, Lisa M. McCarthy, William McDonald, Raha Eskandari, Yanrong Maggie Yang, Douglas M. Salzwedel, Parag Goyal · 2026
Read Beta-Blocker Discontinuation in Acute Heart Failure by Nima Alaeiilkhchi, Wade Thompson, Lisa M. McCarthy, William McDonald, Raha Eskandari, Yanrong Maggie Yang, Douglas M. Salzwedel, Parag Goyal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311924.txt.
Description
Nima Alaeiilkhchi and co-authors give a 2026 systematic review on stopping versus continuing beta-blockers during hospital stays for acute heart failure. The right call during a flare has long been unsettled.
Searches through September 2025 found thirteen studies: one trial with 147 patients and twelve cohorts with 14,654. Pooled cohort data left the effect on in-hospital death unclear, with widely spread results. Short-term stopping may raise death risk up to three months, with a pooled hazard ratio of 2.30 across two studies in this review. The single trial was too small to settle anything. More trial data are needed.
Catalog record
| CREATOR | Nima Alaeiilkhchi, Wade Thompson, Lisa M. McCarthy, William McDonald, Raha Eskandari, Yanrong Maggie Yang, Douglas M. Salzwedel, Parag Goyal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52675 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |